Your browser doesn't support javascript.
loading
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis.
Lambros, Maryou B; Seed, George; Sumanasuriya, Semini; Gil, Veronica; Crespo, Mateus; Fontes, Mariane; Chandler, Rob; Mehra, Niven; Fowler, Gemma; Ebbs, Berni; Flohr, Penny; Miranda, Susana; Yuan, Wei; Mackay, Alan; Ferreira, Ana; Pereira, Rita; Bertan, Claudia; Figueiredo, Ines; Riisnaes, Ruth; Rodrigues, Daniel Nava; Sharp, Adam; Goodall, Jane; Boysen, Gunther; Carreira, Suzanne; Bianchini, Diletta; Rescigno, Pasquale; Zafeiriou, Zafeiris; Hunt, Joanne; Moloney, Deirdre; Hamilton, Lucy; Neves, Rui P; Swennenhuis, Joost; Andree, Kiki; Stoecklein, Nikolas H; Terstappen, Leon W M M; de Bono, Johann S.
Afiliação
  • Lambros MB; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Seed G; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Sumanasuriya S; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Gil V; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Crespo M; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Fontes M; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Chandler R; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Mehra N; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Fowler G; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Ebbs B; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Flohr P; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Miranda S; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Yuan W; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Mackay A; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Ferreira A; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Pereira R; Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer, Research, London, United Kingdom.
  • Bertan C; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Figueiredo I; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Riisnaes R; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Rodrigues DN; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Sharp A; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Goodall J; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Boysen G; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Carreira S; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Bianchini D; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Rescigno P; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Zafeiriou Z; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Hunt J; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Moloney D; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Hamilton L; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Neves RP; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Swennenhuis J; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Andree K; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Stoecklein NH; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Terstappen LWMM; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • de Bono JS; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
Clin Cancer Res ; 24(22): 5635-5644, 2018 11 15.
Article em En | MEDLINE | ID: mdl-30093450
ABSTRACT

Purpose:

Circulating tumor cells (CTCs) have clinical relevance, but their study has been limited by their low frequency.Experimental

Design:

We evaluated liquid biopsies by apheresis to increase CTC yield from patients suffering from metastatic prostate cancer, allow precise gene copy-number calls, and study disease heterogeneity.

Results:

Apheresis was well tolerated and allowed the separation of large numbers of CTCs; the average CTC yield from 7.5 mL of peripheral blood was 167 CTCs, whereas the average CTC yield per apheresis (mean volume 59.5 mL) was 12,546 CTCs. Purified single CTCs could be isolated from apheresis product by FACS sorting; copy-number aberration (CNA) profiles of 185 single CTCs from 14 patients revealed the genomic landscape of lethal prostate cancer and identified complex intrapatient, intercell, genomic heterogeneity missed on bulk biopsy analyses.

Conclusions:

Apheresis facilitated the capture of large numbers of CTCs noninvasively with minimal morbidity and allowed the deconvolution of intrapatient heterogeneity and clonal evolution. Clin Cancer Res; 24(22); 5635-44. ©2018 AACR.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Remoção de Componentes Sanguíneos / Biomarcadores Tumorais / Análise de Célula Única / Biópsia Líquida Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Remoção de Componentes Sanguíneos / Biomarcadores Tumorais / Análise de Célula Única / Biópsia Líquida Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article